CAD106
Showing 1 - 25 of 96
Alzheimer Trial in United States (CAD106)
Completed
- Alzheimer Disease
- CAD106
-
Costa Mesa, California
- +7 more
Dec 11, 2020
Alzheimer's Disease Trial in United States (Placebo, CAD106)
Completed
- Alzheimer's Disease
- Placebo
- CAD106
-
Costa Mesa, California
- +9 more
Dec 11, 2020
Alzheimer's Disease Trial in Worldwide (CAD106, Placebo, Alum)
Completed
- Alzheimer's Disease
- CAD106
- +3 more
-
Costa Mesa, California
- +30 more
Mar 2, 2021
Alzheimer Trial in Worldwide (Placebo, CAD106)
Completed
- Alzheimer Disease
- Placebo
- CAD106
-
Bordeaux, France
- +3 more
Feb 8, 2020
Alzheimer Trial in Worldwide (CAD106)
Completed
- Alzheimer Disease
- CAD106
-
Bordeaux, France
- +3 more
Feb 8, 2020
Alzheimers Disease Trial in Worldwide (biological, other, drug)
Terminated
- Alzheimers Disease
- CAD106 Immunotherapy
- +4 more
-
Phoenix, Arizona
- +128 more
Jul 7, 2021
Tuberculosis Trial (Quantiferon Gold, HIV serology, Respiratory secretion culture (sputum or gastric aspirate_)
Not yet recruiting
- Tuberculosis
- Quantiferon Gold
- +5 more
- (no location specified)
Oct 27, 2023
Angina, Stable, Angina Pectoris, Variant, Microvascular Angina Trial in Clydebank, Larbert, Glasgow (Stratified medicine
Active, not recruiting
- Angina, Stable
- +2 more
- Stratified medicine involving a diagnostic intervention
-
Clydebank, Dunbartonshire, United Kingdom
- +2 more
Jan 6, 2022
Coronary Artery Ectasia Trial (Rivaroxaban 2.5 Mg Oral Tablet twice daily, Clopidogrel 75 Mg Oral Tablet, Aspirin tablet 75 mg)
Not yet recruiting
- Coronary Artery Ectasia
- Rivaroxaban 2.5 Mg Oral Tablet twice daily
- +2 more
- (no location specified)
Jan 30, 2023
Hepatocellular Carcinoma Trial in Nanjing (Idarubicin Hydrochloride for Injection)
Recruiting
- Hepatocellular Carcinoma
- Idarubicin Hydrochloride for Injection
-
Nanjing, Jiangsu, ChinaZhongda Hospital, Southeast University
Dec 28, 2022
Artificial Intelligence Second Mesio-buccal Canal of Maxillary
Recruiting
- Artificial Intelligence
- deep learning model
-
Cairo, EgyptFaculty of dentistry cairo university
Apr 20, 2022
Heart Disease Trial in Bouge, Ottawa (Fractional Flow Reserve (FFR))
Active, not recruiting
- Heart Disease
- Fractional Flow Reserve (FFR)
-
Bouge, Belgium
- +1 more
Jan 9, 2023
Periodontal Disease, Gingival Disease Trial in Van (mechanical cord usage)
Completed
- Periodontal Disease
- Gingival Disease
- mechanical cord usage
-
Van, TurkeyBeyza Ünalan Değirmenci
Apr 21, 2021
Predictors of Foot Amputation in Diabetic Foot Ulcers
Completed
- Diabetic Foot
- +3 more
- Retrospective observational study of diabetic foot ulcer
-
Quetta, Balochistan, PakistanBolan Medical Complex Hospital Quetta, Pakistan
Oct 22, 2022
Orthognathic Surgery Trial in Cairo (Postsurgical computer guided functional appliance)
Recruiting
- Orthognathic Surgery
- Postsurgical computer guided functional appliance
-
Cairo, Egyptoutpatient clinic of Oral and Maxillofacial Surgery department-
Aug 16, 2021
Complete Revascularization, Coronary Artery Bypass Grafting, Multivessel Coronary Artery Disease Trial (Inferior
Not yet recruiting
- Complete Revascularization
- +2 more
- Inferior part-sternotomy
- Full median sternotomy
- (no location specified)
Apr 27, 2023
Asymptomatic, High Risk, Diabetes Trial in Belgrade (Echocardiography, CT angiography)
Recruiting
- Asymptomatic
- +2 more
- Echocardiography
- CT angiography
-
Belgrade, SerbiaClinical Centre of Serbia
Aug 11, 2021
Coronary Artery Disease, Myocardial Infarction Trial in Ljubljana (Exercise training)
Completed
- Coronary Artery Disease
- Myocardial Infarction
- Exercise training
-
Ljubljana, SloveniaUniversity Medical Centre Ljubljana
Dec 8, 2021
Long-Term Effects of Subclinical CAD on Cardiac Function
Withdrawn
- Cardiovascular Diseases
- +3 more
- (no location specified)
Jan 27, 2021
Leishmaniasis, Cutaneous Trial in Medellín (Experimental topical (Curaleish Topical))
Withdrawn
- Leishmaniasis, Cutaneous
- Experimental topical (Curaleish Topical)
-
Medellín, Antioquia, ColombiaProgram for Research and Control in Tropical Diseases - PECET
Jun 2, 2022
Coronary Artery Disease, Human Immunodeficiency Virus Trial in Baltimore (Colchicine, Placebo)
Completed
- Coronary Artery Disease
- Human Immunodeficiency Virus
- Colchicine
- Placebo
-
Baltimore, MarylandJohns Hopkins Hospital
Sep 20, 2021
Leishmaniasis, Cutaneous Trial in Medellín (Arnica Tincture)
Not yet recruiting
- Leishmaniasis, Cutaneous
- Arnica Tincture
-
Medellín, Antioquia, ColombiaProgram for Research and Control in Tropical Diseases - PECET
Jun 4, 2022
Multiple Electrode Aggregometry & Clopidogrel Resistance
Completed
- Type 2 Diabetes Mellitus (T2DM)
- +2 more
-
Athens, Haidari, Athens, Greece
- +2 more
Apr 8, 2021
Risk Markers in the Acute Coronary Syndromes
Completed
- Chest Pain
- +3 more
-
Stavanger, Rogaland, NorwayStavanger University Hospital
Sep 1, 2021